Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K (1998)
EMBO JOURNAL 17(17): 5238-5248.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Fernandez-Catalan, C;
Bode, W;
Huber, R;
Turk, D;
Calvete, JJ;
Lichte, A;
Tschesche, HaraldUniBi;
Maskos, K
Einrichtung
Abstract / Bemerkung
The proteolytic activity of matrix metalloproteinases (MMPs) towards extracellular matrix components is held in check by the tissue inhibitors of metalloproteinases (TIMPs). The binary complex of TIMP-2 and membrane-type-1 MMP (MT1-MMP) forms a cell surface located 'receptor' involved in pro-MMP-2 activation. We have solved the 2.75 Angstrom crystal structure of the complex between the catalytic domain of human MT1-MMP (cdMT1-MMP) and bovine TIMP-2. In comparison with our previously determined MMP-3-TIMP-1 complex, both proteins are considerably tilted to one another and show new features. CdMT1-MMP, apart from exhibiting the classical MMP fold, displays two large insertions remote from the active-site cleft that might be important for interaction with macromolecular substrates. The TIMP-2 polypeptide chain, as in TIMP-1, folds into a continuous wedge; the A-B edge loop is much more elongated and tilted, however, wrapping around the S-loop and the beta-sheet rim of the MT1-MMP, In addition, both C-terminal edge loops make more interactions with the target enzyme. The C-terminal acidic tail of TIMP-2 is disordered but might adopt a defined structure upon binding to pro-MMP-2; the Ser2 side-chain of TIMP-2 extends into the voluminous S1' specificity pocket of cdMT1-MMP, with its O gamma pointing towards the carboxylate of the catalytic Glu240. The lower affinity of TIMP-1 for MT1-MMP compared with TIMP-2 might be explained by a reduced number of favourable interactions.
Stichworte
crystal structure;
progelatinase A activator;
proteinase complex;
tissue inhibitor of metalloproteinases;
matrix metalloproteinase
Erscheinungsjahr
1998
Zeitschriftentitel
EMBO JOURNAL
Band
17
Ausgabe
17
Seite(n)
5238-5248
ISSN
0261-4189
eISSN
1460-2075
Page URI
https://pub.uni-bielefeld.de/record/1624817
Zitieren
Fernandez-Catalan C, Bode W, Huber R, et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL. 1998;17(17):5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., et al. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL, 17(17), 5238-5248. https://doi.org/10.1093/emboj/17.17.5238
Fernandez-Catalan, C, Bode, W, Huber, R, Turk, D, Calvete, JJ, Lichte, A, Tschesche, Harald, and Maskos, K. 1998. “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”. EMBO JOURNAL 17 (17): 5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., and Maskos, K. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL 17, 5238-5248.
Fernandez-Catalan, C., et al., 1998. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL, 17(17), p 5238-5248.
C. Fernandez-Catalan, et al., “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”, EMBO JOURNAL, vol. 17, 1998, pp. 5238-5248.
Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J.J., Lichte, A., Tschesche, H., Maskos, K.: Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO JOURNAL. 17, 5238-5248 (1998).
Fernandez-Catalan, C, Bode, W, Huber, R, Turk, D, Calvete, JJ, Lichte, A, Tschesche, Harald, and Maskos, K. “Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor”. EMBO JOURNAL 17.17 (1998): 5238-5248.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
INTACT
1 Eintrag gefunden, die diesen Artikel zitieren
UNIPROT
2 Einträge gefunden, die diesen Artikel zitieren
PDB
2 Einträge gefunden, die diesen Artikel zitieren
x-ray diffraction (PDB: 1buv)
Protein structure name: crystal structure of the mt1-mmp-timp-2 complex
Public wwPDB file in PDB format
Protein structure name: crystal structure of the mt1-mmp-timp-2 complex
Public wwPDB file in PDB format
x-ray diffraction (PDB: 1bqq)
Protein structure name: crystal structure of the mt1-mmp--timp-2 complex
Public wwPDB file in PDB format
Protein structure name: crystal structure of the mt1-mmp--timp-2 complex
Public wwPDB file in PDB format
INTERPRO
1 Eintrag gefunden, die diesen Artikel zitieren
132 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Insights into MMP-TIMP interactions.
Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K., Ann N Y Acad Sci 878(), 1999
PMID: 10415721
Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K., Ann N Y Acad Sci 878(), 1999
PMID: 10415721
Tissue inhibitors of matrix metalloproteinases in cancer.
Blavier L, Henriet P, Imren S, Declerck YA., Ann N Y Acad Sci 878(), 1999
PMID: 10415723
Blavier L, Henriet P, Imren S, Declerck YA., Ann N Y Acad Sci 878(), 1999
PMID: 10415723
Analysis of the interaction of TIMP-2 and MMPs: engineering the changes.
Hutton M, Butler GS, Wattam BA, Willenbrock F, Williamson RA, Murphy G., Ann N Y Acad Sci 878(), 1999
PMID: 10415762
Hutton M, Butler GS, Wattam BA, Willenbrock F, Williamson RA, Murphy G., Ann N Y Acad Sci 878(), 1999
PMID: 10415762
Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?
Tymms MJ., Clin Exp Optom 82(4), 1999
PMID: 12482286
Tymms MJ., Clin Exp Optom 82(4), 1999
PMID: 12482286
Membrane associated matrix metalloproteinases in metastasis.
Ellerbroek SM, Stack MS., Bioessays 21(11), 1999
PMID: 10517867
Ellerbroek SM, Stack MS., Bioessays 21(11), 1999
PMID: 10517867
Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.
Tuuttila A, Morgunova E, Bergmann U, Lindqvist Y, Maskos K, Fernandez-Catalan C, Bode W, Tryggvason K, Schneider G., J Mol Biol 284(4), 1998
PMID: 9837731
Tuuttila A, Morgunova E, Bergmann U, Lindqvist Y, Maskos K, Fernandez-Catalan C, Bode W, Tryggvason K, Schneider G., J Mol Biol 284(4), 1998
PMID: 9837731
47 References
Daten bereitgestellt von Europe PubMed Central.
Tissue inhibitors of matrix metalloendopeptidases.
Murphy G, Willenbrock F., Meth. Enzymol. 248(), 1995
PMID: 7674941
Murphy G, Willenbrock F., Meth. Enzymol. 248(), 1995
PMID: 7674941
The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.
Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ., Biochem. J. 283 ( Pt 3)(), 1992
PMID: 1317162
Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ., Biochem. J. 283 ( Pt 3)(), 1992
PMID: 1317162
Activation mechanisms of matrix metalloproteinases.
Nagase H., Biol. Chem. 378(3-4), 1997
PMID: 9165065
Nagase H., Biol. Chem. 378(3-4), 1997
PMID: 9165065
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P., Proc. Natl. Acad. Sci. U.S.A. 92(7), 1995
PMID: 7708715
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P., Proc. Natl. Acad. Sci. U.S.A. 92(7), 1995
PMID: 7708715
Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.
Olson MW, Gervasi DC, Mobashery S, Fridman R., J. Biol. Chem. 272(47), 1997
PMID: 9368077
Olson MW, Gervasi DC, Mobashery S, Fridman R., J. Biol. Chem. 272(47), 1997
PMID: 9368077
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G., Eur. J. Biochem. 250(3), 1997
PMID: 9461298
Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
Pei D, Weiss SJ., J. Biol. Chem. 271(15), 1996
PMID: 8621565
Pei D, Weiss SJ., J. Biol. Chem. 271(15), 1996
PMID: 8621565
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.
Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W., FEBS Lett. 338(2), 1994
PMID: 8307185
Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W., FEBS Lett. 338(2), 1994
PMID: 8307185
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M., FEBS Lett. 393(1), 1996
PMID: 8804434
Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M., FEBS Lett. 393(1), 1996
PMID: 8804434
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG, Krutzsch HC, Liotta LA., J. Biol. Chem. 264(29), 1989
PMID: 2793861
Stetler-Stevenson WG, Krutzsch HC, Liotta LA., J. Biol. Chem. 264(29), 1989
PMID: 2793861
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 268(19), 1993
PMID: 8314771
Strongin AY, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 268(19), 1993
PMID: 8314771
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 270(10), 1995
PMID: 7890645
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 270(10), 1995
PMID: 7890645
Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family.
Takino T, Sato H, Shinagawa A, Seiki M., J. Biol. Chem. 270(39), 1995
PMID: 7559440
Takino T, Sato H, Shinagawa A, Seiki M., J. Biol. Chem. 270(39), 1995
PMID: 7559440
cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment.
Will H, Hinzmann B., Eur. J. Biochem. 231(3), 1995
PMID: 7649159
Will H, Hinzmann B., Eur. J. Biochem. 231(3), 1995
PMID: 7649159
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H, Atkinson SJ, Butler GS, Smith B, Murphy G., J. Biol. Chem. 271(29), 1996
PMID: 8663332
Will H, Atkinson SJ, Butler GS, Smith B, Murphy G., J. Biol. Chem. 271(29), 1996
PMID: 8663332
The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G., Biochemistry 32(16), 1993
PMID: 8476862
Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G., Biochemistry 32(16), 1993
PMID: 8476862
Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family.
Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J., Biochemistry 33(39), 1994
PMID: 7918391
Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J., Biochemistry 33(39), 1994
PMID: 7918391
Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.
Williamson RA, Carr MD, Frenkiel TA, Feeney J, Freedman RB., Biochemistry 36(45), 1997
PMID: 9374866
Williamson RA, Carr MD, Frenkiel TA, Feeney J, Freedman RB., Biochemistry 36(45), 1997
PMID: 9374866
Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF Jr., FASEB J. 5(8), 1991
PMID: 1850705
Woessner JF Jr., FASEB J. 5(8), 1991
PMID: 1850705
Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J., J. Biol. Chem. 273(2), 1998
PMID: 9422789
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J., J. Biol. Chem. 273(2), 1998
PMID: 9422789
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 9724659
PubMed | Europe PMC
Suchen in